The OS benefit did not reach statistical significance in the IPTW-adjusted analysis, likely due to the small number of patients receiving maintenance therapy.
← all excerpts
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.
1
—
—